| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/21/2009 | CA2458339C Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009087649A1 Renin inhibitors |
| 07/16/2009 | WO2009087564A1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain |
| 07/16/2009 | WO2009087058A1 Process for the preparation of asenapine and intermediate products used in said process |
| 07/16/2009 | WO2009086873A1 Corrosion inhibitors having increased biological degradability and minimized toxicity |
| 07/16/2009 | WO2009086872A1 Corrosion inhibitors having increased biological degradability and minimized toxicity |
| 07/16/2009 | US20090182154 Combinatorial library approach to iminocyclitols with biological activity |
| 07/16/2009 | US20090182139 Process for the preparation of an n-alkyl lactam with improved colour quality |
| 07/16/2009 | US20090182030 Process for the preparation of amorphous calcium salt of atorvastatin |
| 07/16/2009 | CA2710800A1 Process for the preparation of asenapine and intermediate products used in said process |
| 07/15/2009 | EP1745048A4 Simple stereocontrolled synthesis of salinosporamide a |
| 07/15/2009 | CN101481346A Preparation of carbapenem antibiotic side chain |
| 07/15/2009 | CN100513395C Method of preparing polyhydroxy annular nitrone |
| 07/15/2009 | CN100513394C Ketopyrrolidine sulfurate in liquid and its prpearing method |
| 07/15/2009 | CN100513393C Method for purifying n-methyl-2-pyrrolidone |
| 07/15/2009 | CN100513392C Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 07/14/2009 | USRE40851 3,3-diphenylpropylamines, their use and preparation |
| 07/14/2009 | US7560589 Cycloalkylidene compounds as modulators of estrogen receptor |
| 07/14/2009 | US7560572 Therapy for micorbiocide infections; cystic fibrosis; controlling gene expression; antibiotic; immunology stimulant |
| 07/14/2009 | US7560571 anticarcinogenic agent, 3-{4-[3-(2-Fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-2-carboxamide, for treating cancer; modulating Protein kinases, relieve the side effect of chemotherapy |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
| 07/14/2009 | CA2309279C Polymerization process with living characteristics and polymers made therefrom |
| 07/09/2009 | WO2009084827A2 Synthetic intermediates, process for preparing pyrrolylheptanoic acid derivatives therefrom |
| 07/09/2009 | WO2009084493A1 Optically active 3-aminopyrrolidine salt, process for production thereof, and method for optical resolution of 3-aminopyrrolidine |
| 07/09/2009 | WO2009084283A1 Cyclic compound, its metal complex, and modified metal complex |
| 07/09/2009 | WO2009067491A3 Derivatized tertiary amines and uses thereof |
| 07/09/2009 | US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism |
| 07/09/2009 | US20090176861 Cathepsin cysteine protease inhibitors |
| 07/09/2009 | US20090176860 Zofenopril calcium |
| 07/09/2009 | US20090176859 Cathepsin cysteine protease inhibitors |
| 07/09/2009 | US20090176847 Dicyclooctane Derivatives, Preparation Processes and Medical Uses Thereof |
| 07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
| 07/09/2009 | US20090176782 Inhibitors of tace |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176307 Compounds, Compositions and Methods |
| 07/09/2009 | US20090176279 Bioreactive agents |
| 07/09/2009 | CA2710808A1 Cyclic compound, its metal complex and modified metal complex |
| 07/09/2009 | CA2709784A1 Method for altering the lifespan of eukaryotic organisms |
| 07/08/2009 | EP2077268A1 Process for preparing inhibitors of nucleoside metabolism |
| 07/08/2009 | EP2077261A1 Method for producing succinimide compound |
| 07/08/2009 | EP2077260A1 Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof |
| 07/08/2009 | EP2076492A2 Non-nucleoside reverse transcriptase inhibitors |
| 07/08/2009 | EP2076491A1 New benzamide derivatives as bradykinin antagonists |
| 07/08/2009 | EP2076487A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 07/08/2009 | EP1843767B1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders. |
| 07/08/2009 | EP1401808B1 Gpe analogs and peptidomimetics |
| 07/08/2009 | EP1278726B1 Method for producing cyclic lactams |
| 07/08/2009 | CN101479241A Pyrrole derivatives and their methods of use |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN101475523A 3-acyl pyrroline-2-ketoxime ether compound, and preparation and use thereof |
| 07/08/2009 | CN101475522A Preparation of menthyl pyroglutamate |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100509779C Dithiocarbamate |
| 07/08/2009 | CN100509771C Method for the production of sulphamic acid halogenides |
| 07/07/2009 | US7557215 Anthraquinone compounds as anti cancer compounds |
| 07/07/2009 | US7557137 Gamma-lactams as beta-secretase inhibitors |
| 07/07/2009 | US7557136 Pyrrolidine derivatives as oxytocin antagonists |
| 07/07/2009 | US7557126 Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 07/07/2009 | US7556931 Furosemide modulators of HM74 |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/02/2009 | WO2009082437A2 Selective androgen receptor modulators (sarms) and uses thereof |
| 07/02/2009 | WO2009082362A1 A method for producing statins in pure form |
| 07/02/2009 | WO2009082086A1 Process for preparing of n-methyl pyrrolidone |
| 07/02/2009 | WO2009080708A1 Use of enantiopure n-sulphonyl pyroglutamic acid as resolving agent |
| 07/02/2009 | WO2009080500A1 Process for the preparation of pyrido [2,1-a] isoquinoline derivatives |
| 07/02/2009 | WO2009080335A1 Process for the preparation of 6-substituted-1-(2h)-isoquinolinones |
| 07/02/2009 | WO2009079683A1 Translocator protein ligands |
| 07/02/2009 | WO2009012375A3 Squarate kinase inhibitors |
| 07/02/2009 | US20090171100 Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives |
| 07/02/2009 | US20090171099 Process for the production of amorphous atorvastatin calcium |
| 07/02/2009 | US20090171095 Production method of heterocyclic mercapto compound |
| 07/02/2009 | US20090170916 4,5-substituted pyrazole-3-carboxylic acids/esters/salts; D-amino acid oxidase (DAAO) inhibitors; increase D-Serine level; reduce level of toxic products of D-Serine oxidation; activate N-methyl-D-aspartate NMDA-glutamate receptors; neuropathic agent, schizophrenia, Alzheimer's, anaxia |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170870 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 07/02/2009 | US20090170841 Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170824 Diarylsulfones as 5-HT2A Antagonists |
| 07/02/2009 | CA2710447A1 Process for the preparation of 6-substituted-1-(2h)-isoquinolinones |
| 07/02/2009 | CA2710016A1 Translocator protein ligands |
| 07/02/2009 | CA2709677A1 Selective androgen receptor modulators (sarms) and uses thereof |
| 07/02/2009 | CA2708314A1 Process for the preparation of pyrido [2,1-a] isoquinoline derivatives |
| 07/01/2009 | EP2075246A1 A process for preparation of amorphous form of atorvastatin hemi-calcium salt |
| 07/01/2009 | EP2074102A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 07/01/2009 | EP2074097A2 Compounds for treating proliferative disorders |
| 07/01/2009 | EP2074087A2 Synthesis of pyrrolidine compounds |
| 07/01/2009 | EP2074086A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 07/01/2009 | EP2074083A1 New sulfonamide derivatives as bradykinin antagonists |
| 07/01/2009 | EP1861365B1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor |
| 07/01/2009 | CN101472889A Alkoxyalkyl-substituted cyclic ketoenols |
| 07/01/2009 | CN101472888A Optical pure chromocor derivate for treating proliferative lesion and preparation method thereof |
| 07/01/2009 | CN101472887A Cyclopropyl amine derivatives |
| 07/01/2009 | CN101468963A Preparation of amorphous atorvastatin calcium |
| 07/01/2009 | CN101468962A Method for preparing (S)-2,2-phenyl-2-(3-pyrrolidinyl) acetamide |
| 07/01/2009 | CN100507549C Acoustic sensors and methods |